Results 181 to 190 of about 117,801 (299)

Hereditary Breast and Ovarian Cancer [PDF]

Deutsches Ärzteblatt international, 2011
Meindl, Alfons, Ditsch, Nina, Kast, Karin, Rhiem, Kerstin, Schmutzler, Rita K.   +4 more
openaire   +1 more source

Development of a Prediction Model for Progression Risk in High‐Grade Gliomas Based on Habitat Radiomics and Pathomics

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To investigate the value of constructing models based on habitat radiomics and pathomics for predicting the risk of progression in high‐grade gliomas. Methods This study conducted a retrospective analysis of preoperative magnetic resonance (MR) images and pathological sections from 72 patients diagnosed with high‐grade gliomas (52 ...
Yuchen Zhu, Yuxi Gong, Weilin Xu, Xingjian Sun, Gefei Jiang, Lei Qiu, Kexin Shi, Mengxing Wu, Yinjiao Fei, Jinling Yuan, Jinyan Luo, Yurong Li, Yuandong Cao, Minhong Pan, Shu Zhou   +14 more
wiley   +1 more source

Hereditary Breast Cancer: Comprehensive Risk Assessment and Prevention Strategies. [PDF]

Genes (Basel)
Manna EDF, Serrano D, Cazzaniga L, Mannucci S, Zanzottera C, Fava F, Aurilio G, Guerrieri-Gonzaga A, Risti M, Calvello M, Feroce I, Marabelli M, Altemura C, Bertario L, Bonanni B, Lazzeroni M.   +15 more
europepmc   +1 more source

A comprehensive study on surveillance outcomes of a male population followed at a hereditary breast cancer high-risk consultation at a Portuguese tertiary hospital. [PDF]

J Cancer Res Clin Oncol, 2023
Oliveira MJ, Costa S, Magalhães A, Garrido L, Peleteiro B, Fougo JL, Castedo S.   +6 more
europepmc   +1 more source

Unraveling the Molecular Mechanisms of Glioma Recurrence: A Study Integrating Single‐Cell and Spatial Transcriptomics

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Glioma recurrence severely impacts patient prognosis, with current treatments showing limited efficacy. Traditional methods struggle to analyze recurrence mechanisms due to challenges in assessing tumor heterogeneity, spatial dynamics, and gene networks.
Lei Qiu, Yinjiao Fei, Jiaxuan Ding, Kexin Shi, Jinyan Luo, Yuchen Zhu, Xingjian Sun, Gefei Jiang, Yuandong Cao, Weilin Xu, Shu Zhou   +10 more
wiley   +1 more source

Mono-allelic MUTYH mutation as the likely inherited etiology of hereditary breast cancer in a patient from a multi-cancer family- report of a family and literature review. [PDF]

BMC Med Genomics
Sarmadi A, Javanmard SH, Zeinalian M, Hosseinzadeh M, Tabatabaiefar MA.   +4 more
europepmc   +1 more source

An overview of genetic services delivery for hereditary breast cancer. [PDF]

Breast Cancer Res Treat, 2022
Reid S, Spalluto LB, Lang K, Weidner A, Pal T.   +4 more
europepmc   +1 more source

Clinical Spectrum and Outcomes of SOX1 Antibody‐Associated Paraneoplastic Neurological Syndromes: A Chinese Cohort Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background SOX1 antibody‐positive paraneoplastic neurological syndromes (PNS) exhibit significant population‐specific clinical heterogeneity. While Western cohorts predominantly manifest Lambert‐Eaton myasthenic syndrome (65%–80%), comprehensive clinical characterization and treatment response data in Asian populations remain critically ...
Jin‐Long Ye, Zu‐Ying Kuang, Bo Li, Meng‐Qiu Pan, Li‐Hua Zhou, Yang‐Yang Dai, Si‐Fen Xie, Xian‐Guang Lin, Ye‐Peng Hu, Li‐Hong Jiang, Zhan‐Hang Wang, Wei‐Jing Zhang   +11 more
wiley   +1 more source

Application of genetic testing criteria for hereditary breast cancer in South Africa. [PDF]

Breast Cancer Res Treat
Osler TS, Schoeman M, Pretorius WJS, Mathew CG, Edge J, Urban MF.   +5 more
europepmc   +1 more source

Double heterozygous pathogenic variants prevalence in a cohort of patients with hereditary breast cancer. [PDF]

Front Oncol, 2022
Megid TBC, Barros-Filho MC, Pisani JP, Achatz MI.   +3 more
europepmc   +1 more source